ESTRO PT 2018

Facts: All technological advances have been introduced without Phase III trial evidence first (example: IMRT)

The confusing and unique situation in particles is, that its opponents REQUIRE Phase III trials BEFORE and as PREREQUISITE to permit particle therapy’s application

That is distinctly different from arguing that Phase III trials will ultimately be a useful tool in the final evaluation of particle therapy’s superiority or in specific diseases or disease site.